|
1
|
How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology.
|
Eur Heart J
|
2007
|
10.38
|
|
2
|
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA).
|
Eur Heart J
|
2013
|
6.17
|
|
3
|
Altered microRNA expression in human heart disease.
|
Physiol Genomics
|
2007
|
5.64
|
|
4
|
Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial.
|
JAMA
|
2013
|
5.41
|
|
5
|
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).
|
Eur Heart J
|
2014
|
5.21
|
|
6
|
ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC-1.
|
Nat Med
|
2011
|
3.96
|
|
7
|
Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy.
|
Eur J Heart Fail
|
2010
|
3.90
|
|
8
|
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
|
Eur Heart J
|
2016
|
3.83
|
|
9
|
The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial.
|
Lancet
|
2012
|
3.66
|
|
10
|
Exercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction: results of the Ex-DHF (Exercise training in Diastolic Heart Failure) pilot study.
|
J Am Coll Cardiol
|
2011
|
3.13
|
|
11
|
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
|
Eur J Heart Fail
|
2016
|
2.91
|
|
12
|
Moderate hypothermia for severe cardiogenic shock (COOL Shock Study I & II).
|
Resuscitation
|
2012
|
2.70
|
|
13
|
Calcium cycling in congestive heart failure.
|
J Mol Cell Cardiol
|
2002
|
2.46
|
|
14
|
Insulin causes [Ca2+]i-dependent and [Ca2+]i-independent positive inotropic effects in failing human myocardium.
|
Circulation
|
2005
|
1.93
|
|
15
|
Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes.
|
Proc Natl Acad Sci U S A
|
2002
|
1.88
|
|
16
|
N-terminal pro-brain natriuretic peptide or troponin testing followed by echocardiography for risk stratification of acute pulmonary embolism.
|
Circulation
|
2005
|
1.86
|
|
17
|
Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure.
|
Eur Heart J
|
2008
|
1.83
|
|
18
|
Influence of pyruvate on contractile performance and Ca(2+) cycling in isolated failing human myocardium.
|
Circulation
|
2002
|
1.73
|
|
19
|
Long-term cardiac-targeted RNA interference for the treatment of heart failure restores cardiac function and reduces pathological hypertrophy.
|
Circulation
|
2009
|
1.71
|
|
20
|
First prospective, multi-centre clinical experience with a novel left ventricular quadripolar lead.
|
Europace
|
2011
|
1.70
|
|
21
|
Exercise training in heart failure: from theory to practice. A consensus document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation.
|
Eur J Heart Fail
|
2011
|
1.61
|
|
22
|
Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology.
|
Eur J Heart Fail
|
2009
|
1.61
|
|
23
|
Differential interaction of clinical characteristics with key functional parameters in heart failure with preserved ejection fraction--results of the Aldo-DHF trial.
|
Int J Cardiol
|
2013
|
1.56
|
|
24
|
Peripartum cardiomyopathy--a new treatment option by inhibition of prolactin secretion.
|
Am J Obstet Gynecol
|
2008
|
1.51
|
|
25
|
Increased SR Ca2+ cycling contributes to improved contractile performance in SERCA2a-overexpressing transgenic rats.
|
Cardiovasc Res
|
2005
|
1.51
|
|
26
|
Selective upregulation of beta1-adrenergic receptors and dephosphorylation of troponin I in end-stage heart failure patients supported by ventricular assist devices.
|
J Mol Cell Cardiol
|
2006
|
1.50
|
|
27
|
Emerging roles of inositol 1,4,5-trisphosphate signaling in cardiac myocytes.
|
J Mol Cell Cardiol
|
2008
|
1.50
|
|
28
|
Renal effects of the angiotensin receptor neprilysin inhibitor LCZ696 in patients with heart failure and preserved ejection fraction.
|
Eur J Heart Fail
|
2015
|
1.49
|
|
29
|
Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology.
|
Eur J Heart Fail
|
2011
|
1.40
|
|
30
|
Interferon-gamma induces chronic active myocarditis and cardiomyopathy in transgenic mice.
|
Am J Pathol
|
2007
|
1.26
|
|
31
|
Heart failure-associated changes in RNA splicing of sarcomere genes.
|
Circ Cardiovasc Genet
|
2010
|
1.23
|
|
32
|
Na+-dependent SR Ca2+ overload induces arrhythmogenic events in mouse cardiomyocytes with a human CPVT mutation.
|
Cardiovasc Res
|
2010
|
1.22
|
|
33
|
Expression of ten RGS proteins in human myocardium: functional characterization of an upregulation of RGS4 in heart failure.
|
Cardiovasc Res
|
2002
|
1.21
|
|
34
|
In situ calibration of nucleoplasmic versus cytoplasmic Ca²+ concentration in adult cardiomyocytes.
|
Biophys J
|
2011
|
1.17
|
|
35
|
Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference.
|
Europace
|
2013
|
1.16
|
|
36
|
Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study.
|
Eur J Heart Fail
|
2011
|
1.16
|
|
37
|
Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease.
|
Cardiovasc Res
|
2012
|
1.14
|
|
38
|
EURObservational Research Programme: a worldwide registry on peripartum cardiomyopathy (PPCM) in conjunction with the Heart Failure Association of the European Society of Cardiology Working Group on PPCM.
|
Eur J Heart Fail
|
2014
|
1.13
|
|
39
|
Endothelin-1 enhances nuclear Ca2+ transients in atrial myocytes through Ins(1,4,5)P3-dependent Ca2+ release from perinuclear Ca2+ stores.
|
J Cell Sci
|
2007
|
1.10
|
|
40
|
Functional relevance of the stretch-dependent slow force response in failing human myocardium.
|
Circ Res
|
2004
|
1.07
|
|
41
|
Benefit of Exercise in Atrial Fibrillation: Diastolic Function Matters!
|
J Am Coll Cardiol
|
2016
|
1.06
|
|
42
|
Negative inotropy of the gastric proton pump inhibitor pantoprazole in myocardium from humans and rabbits: evaluation of mechanisms.
|
Circulation
|
2007
|
1.06
|
|
43
|
Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease.
|
Metabolism
|
2013
|
1.04
|
|
44
|
Adherence of heart failure patients to exercise: barriers and possible solutions: a position statement of the Study Group on Exercise Training in Heart Failure of the Heart Failure Association of the European Society of Cardiology.
|
Eur J Heart Fail
|
2012
|
1.04
|
|
45
|
Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document.
|
Eur J Heart Fail
|
2013
|
1.04
|
|
46
|
Galectin-3 in heart failure with preserved ejection fraction.
|
Eur J Heart Fail
|
2013
|
1.03
|
|
47
|
Serum and glucocorticoid inducible kinases in the regulation of the cardiac sodium channel SCN5A.
|
Cardiovasc Res
|
2003
|
1.01
|
|
48
|
Functional cardiac lipolysis in mice critically depends on comparative gene identification-58.
|
J Biol Chem
|
2013
|
1.00
|
|
49
|
Na(+)-Ca(2+) exchanger overexpression predisposes to reactive oxygen species-induced injury.
|
Cardiovasc Res
|
2003
|
0.99
|
|
50
|
Blunted frequency-dependent upregulation of cardiac output is related to impaired relaxation in diastolic heart failure.
|
Eur Heart J
|
2009
|
0.98
|
|
51
|
The cGMP signaling pathway as a therapeutic target in heart failure with preserved ejection fraction.
|
J Am Heart Assoc
|
2013
|
0.98
|
|
52
|
Organization of heart failure management in European Society of Cardiology member countries: survey of the Heart Failure Association of the European Society of Cardiology in collaboration with the Heart Failure National Societies/Working Groups.
|
Eur J Heart Fail
|
2013
|
0.97
|
|
53
|
The slow force response to stretch in atrial and ventricular myocardium from human heart: functional relevance and subcellular mechanisms.
|
Prog Biophys Mol Biol
|
2008
|
0.97
|
|
54
|
Heart failure with normal left ventricular ejection fraction: what is the evidence?
|
Trends Cardiovasc Med
|
2008
|
0.96
|
|
55
|
Impaired left atrial function in heart failure with preserved ejection fraction.
|
Eur J Heart Fail
|
2014
|
0.96
|
|
56
|
The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction.
|
Eur J Heart Fail
|
2010
|
0.95
|
|
57
|
Sodium and the heart: a hidden key factor in cardiac regulation.
|
Cardiovasc Res
|
2003
|
0.93
|
|
58
|
Overexpression of CaMKIIδc in RyR2R4496C+/- knock-in mice leads to altered intracellular Ca2+ handling and increased mortality.
|
J Am Coll Cardiol
|
2011
|
0.93
|
|
59
|
Transcription factor GATA4 is activated but not required for insulin-like growth factor 1 (IGF1)-induced cardiac hypertrophy.
|
J Biol Chem
|
2012
|
0.92
|
|
60
|
Insulin-like growth factor-1 exerts Ca2+-dependent positive inotropic effects in failing human myocardium.
|
Circ Res
|
2003
|
0.92
|
|
61
|
Impact of diabetes on left ventricular diastolic function in patients with arterial hypertension.
|
Eur J Heart Fail
|
2007
|
0.92
|
|
62
|
Intracellular dyssynchrony of diastolic cytosolic [Ca²⁺] decay in ventricular cardiomyocytes in cardiac remodeling and human heart failure.
|
Circ Res
|
2013
|
0.92
|
|
63
|
Spongious hypertrophic cardiomyopathy in patients with mutations in the four-and-a-half LIM domain 1 gene.
|
Circ Cardiovasc Genet
|
2012
|
0.91
|
|
64
|
Stretch-dependent modulation of [Na+]i, [Ca2+]i, and pHi in rabbit myocardium--a mechanism for the slow force response.
|
Cardiovasc Res
|
2005
|
0.91
|
|
65
|
Independence of the blood pressure lowering effect and efficacy of the angiotensin receptor neprilysin inhibitor, LCZ696, in patients with heart failure with preserved ejection fraction: an analysis of the PARAMOUNT trial.
|
Eur J Heart Fail
|
2014
|
0.90
|
|
66
|
Corticotropin-releasing factor receptors and urocortins, links between the brain and the heart.
|
Eur J Pharmacol
|
2010
|
0.89
|
|
67
|
Stretch-dependent slow force response in isolated rabbit myocardium is Na+ dependent.
|
Cardiovasc Res
|
2003
|
0.89
|
|
68
|
Left ventricular dyssynchrony in patients with heart failure and preserved ejection fraction.
|
Eur Heart J
|
2013
|
0.89
|
|
69
|
The seasonal peculiarities of force-frequency relationships in active ground squirrel Spermophilus undulatus ventricle.
|
Cryobiology
|
2007
|
0.88
|
|
70
|
A stepwise psychotherapy intervention for reducing risk in coronary artery disease (SPIRR-CAD) - rationale and design of a multicenter, randomized trial in depressed patients with CAD.
|
J Psychosom Res
|
2011
|
0.88
|
|
71
|
A network against failing hearts--introducing the German "Competence Network Heart Failure".
|
Int J Cardiol
|
2009
|
0.88
|
|
72
|
Serum aldosterone and its relationship to left ventricular structure and geometry in patients with preserved left ventricular ejection fraction.
|
Eur Heart J
|
2011
|
0.88
|
|
73
|
Sex-specific cardiovascular structure and function in heart failure with preserved ejection fraction.
|
Eur J Heart Fail
|
2014
|
0.87
|
|
74
|
Natriuretic peptides in the detection of preclinical diastolic or systolic dysfunction.
|
Clin Res Cardiol
|
2010
|
0.87
|
|
75
|
Impact of obstructive sleep apnoea on diastolic function.
|
Eur Respir J
|
2012
|
0.86
|
|
76
|
Angiotensin II and myosin light-chain phosphorylation contribute to the stretch-induced slow force response in human atrial myocardium.
|
Cardiovasc Res
|
2008
|
0.86
|
|
77
|
Improved systolic and diastolic myocardial function with intracoronary pyruvate in patients with congestive heart failure.
|
Eur J Heart Fail
|
2004
|
0.86
|
|
78
|
cAMP- and Ca²(+) /calmodulin-dependent protein kinases mediate inotropic, lusitropic and arrhythmogenic effects of urocortin 2 in mouse ventricular myocytes.
|
Br J Pharmacol
|
2011
|
0.86
|
|
79
|
A short form of the General Self-Efficacy Scale (GSE-6): Development, psychometric properties and validity in an intercultural non-clinical sample and a sample of patients at risk for heart failure.
|
Psychosoc Med
|
2013
|
0.86
|
|
80
|
Urocortin II enhances contractility in rabbit ventricular myocytes via CRF(2) receptor-mediated stimulation of protein kinase A.
|
Cardiovasc Res
|
2005
|
0.86
|
|
81
|
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure.
|
Rev Esp Cardiol (Engl Ed)
|
2016
|
0.85
|
|
82
|
Prevalence and natural history of heart failure in outpatient HIV-infected subjects: rationale and design of the HIV-HEART study.
|
Eur J Med Res
|
2007
|
0.85
|
|
83
|
Rationale and design of the 'aldosterone receptor blockade in diastolic heart failure' trial: a double-blind, randomized, placebo-controlled, parallel group study to determine the effects of spironolactone on exercise capacity and diastolic function in patients with symptomatic diastolic heart failure (Aldo-DHF).
|
Eur J Heart Fail
|
2010
|
0.85
|
|
84
|
Elevated serum levels of interleukin-10 and tumor necrosis factor α [corrected] are both associated with vital exhaustion in patients with cardiovascular risk factors.
|
Psychosomatics
|
2010
|
0.85
|
|
85
|
Determination of bleeding risk using genetic markers in patients taking phenprocoumon.
|
Eur J Clin Pharmacol
|
2003
|
0.85
|
|
86
|
High plasma levels of N-terminal pro-atrial natriuretic peptide associated with low anxiety in severe heart failure.
|
Psychosom Med
|
2003
|
0.84
|
|
87
|
Direct pro-arrhythmogenic effects of angiotensin II can be suppressed by AT1 receptor blockade in human atrial myocardium.
|
Eur J Heart Fail
|
2008
|
0.83
|
|
88
|
Glucose-transporter-mediated positive inotropic effects in human myocardium of diabetic and nondiabetic patients.
|
Metabolism
|
2009
|
0.83
|
|
89
|
Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial.
|
BMC Endocr Disord
|
2012
|
0.83
|
|
90
|
[2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy].
|
Kardiol Pol
|
2014
|
0.83
|
|
91
|
Structural and functional cardiac analyses using modern and sensitive myocardial techniques in adult Pompe disease.
|
Int J Cardiovasc Imaging
|
2015
|
0.82
|
|
92
|
Functional effects of glucose transporters in human ventricular myocardium.
|
Eur J Heart Fail
|
2010
|
0.82
|
|
93
|
Reduced stretch-induced force response in failing human myocardium caused by impaired Na(+)-contraction coupling.
|
Circ Heart Fail
|
2009
|
0.82
|
|
94
|
Aldosterone to active renin ratio is associated with nocturnal blood pressure in obese and treated hypertensive patients: the Styrian Hypertension Study.
|
J Clin Hypertens (Greenwich)
|
2014
|
0.82
|
|
95
|
Effect of the long-term administration of nebivolol on clinical symptoms, exercise capacity and left ventricular function in patients with heart failure and preserved left ventricular ejection fraction: background, aims and design of the ELANDD study.
|
Clin Res Cardiol
|
2009
|
0.82
|
|
96
|
The myeloperoxidase product hypochlorous acid generates irreversible high-density lipoprotein receptor inhibitors.
|
Arterioscler Thromb Vasc Biol
|
2013
|
0.82
|
|
97
|
Impaired physical quality of life in patients with diastolic dysfunction associates more strongly with neurohumoral activation than with echocardiographic parameters: quality of life in diastolic dysfunction.
|
Am Heart J
|
2011
|
0.81
|
|
98
|
Alternans goes subcellular: a "disease" of the ryanodine receptor?
|
Circ Res
|
2002
|
0.81
|
|
99
|
Sunitinib causes dose-dependent negative functional effects on myocardium and cardiomyocytes.
|
BJU Int
|
2012
|
0.80
|
|
100
|
Cinacalcet hydrochloride for the treatment of hyperparathyroidism.
|
Expert Opin Pharmacother
|
2013
|
0.80
|
|
101
|
Serum gamma-glutamyl transferase and mortality in persons undergoing coronary angiography-The Ludwigshafen Risk and Cardiovascular Health Study.
|
Atherosclerosis
|
2009
|
0.80
|
|
102
|
Hypoinnervation is an early event in experimental myocardial remodelling induced by pressure overload.
|
J Anat
|
2013
|
0.80
|
|
103
|
Aldosterone inhibition in patients with heart failure with preserved ejection fraction--reply.
|
JAMA
|
2013
|
0.79
|
|
104
|
The Biomaterialbank of the German Competence Network of Heart Failure (CNHF) is a valuable resource for biomedical and genetic research.
|
Int J Cardiol
|
2008
|
0.79
|
|
105
|
Circulating aldosterone and mortality in female nursing home residents.
|
Exp Gerontol
|
2013
|
0.78
|
|
106
|
Marinobufagenin in essential hypertension and primary aldosteronism: a cardiotonic steroid with clinical and diagnostic implications.
|
Clin Exp Hypertens
|
2014
|
0.78
|
|
107
|
Heart failure therapy in diabetic patients-comparison with the recent ESC/EASD guideline.
|
Cardiovasc Diabetol
|
2011
|
0.78
|
|
108
|
Atrial myocardium is the predominant inotropic target of adrenomedullin in the human heart.
|
Am J Physiol Heart Circ Physiol
|
2007
|
0.78
|
|
109
|
AMP-activated protein kinase α1 regulates cardiac gap junction protein connexin 43 and electrical remodeling following pressure overload.
|
Cell Physiol Biochem
|
2015
|
0.77
|
|
110
|
Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: results from the EPATH randomized, placebo-controlled trial.
|
J Hypertens
|
2016
|
0.77
|
|
111
|
Homoarginine, kidney function and cardiovascular mortality risk.
|
Nephrol Dial Transplant
|
2014
|
0.77
|
|
112
|
Frequency-dependence of the slow force response.
|
Front Biosci
|
2008
|
0.77
|
|
113
|
A randomized, double-blind, placebo-controlled study to determine the effects of valsartan on exercise time in patients with symptomatic heart failure with preserved ejection fraction.
|
Eur J Heart Fail
|
2009
|
0.77
|
|
114
|
Homoarginine in patients with primary hyperparathyroidism.
|
Am J Med Sci
|
2015
|
0.77
|
|
115
|
Natriuretic peptide vs. clinical information for diagnosis of left ventricular systolic dysfunction in primary care.
|
BMC Fam Pract
|
2008
|
0.77
|
|
116
|
Heart failure with preserved ejection fraction--a growing epidemic or 'The Emperor's New Clothes?'.
|
Eur J Heart Fail
|
2011
|
0.77
|
|
117
|
The role of SR Ca(2+)-content in blunted inotropic responsiveness of failing human myocardium.
|
J Mol Cell Cardiol
|
2002
|
0.77
|
|
118
|
European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society.
|
Europace
|
2015
|
0.77
|
|
119
|
No evidence of nitrate tolerance caused by nebivolol.
|
Ther Adv Cardiovasc Dis
|
2014
|
0.76
|
|
120
|
Cardiopulmonary exercise testing in systolic heart failure in 2014: the evolving prognostic role: a position paper from the committee on exercise physiology and training of the heart failure association of the ESC.
|
Eur J Heart Fail
|
2014
|
0.76
|
|
121
|
NT-proANP and NT-proBNP as prognostic markers in patients with acute decompensated heart failure of different etiologies.
|
Clin Biochem
|
2013
|
0.76
|
|
122
|
Mechanistic insight into the functional and toxic effects of Strophanthidin in the failing human myocardium.
|
Eur J Heart Fail
|
2007
|
0.76
|
|
123
|
Arginase: a modulator of myocardial function.
|
Am J Physiol Heart Circ Physiol
|
2006
|
0.76
|
|
124
|
[2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure].
|
Kardiol Pol
|
2016
|
0.76
|
|
125
|
Left ventricular remodelling in systolic heart failure using ivabradine. Slower is smaller is better?
|
Eur Heart J
|
2011
|
0.75
|
|
126
|
Large-scale genome-wide analysis identifies genetic variants associated with cardiac structure and function.
|
J Clin Invest
|
2017
|
0.75
|
|
127
|
Candesartan vs losartan and mortality in patients with heart failure.
|
JAMA
|
2011
|
0.75
|
|
128
|
Reply: does speckle tracking really improve diagnosis and risk stratification in patients with HF with normal EF?
|
J Am Coll Cardiol
|
2014
|
0.75
|
|
129
|
Natriuretic peptides or psychometric tests? Prognostic markers in congestive heart failure.
|
Heart
|
2008
|
0.75
|
|
130
|
Circulating dopamine and C-peptide levels in fasting nondiabetic hypertensive patients: the Graz Endocrine Causes of Hypertension study.
|
Diabetes Care
|
2012
|
0.75
|
|
131
|
Serum levels of interleukin-6 and interleukin-10 in relation to depression scores in patients with cardiovascular risk factors.
|
Behav Med
|
2011
|
0.75
|
|
132
|
Aldosterone-to-Renin Ratio Is Associated With Reduced 24-Hour Heart Rate Variability and QTc Prolongation in Hypertensive Patients.
|
Medicine (Baltimore)
|
2016
|
0.75
|
|
133
|
A Stepwise Psychotherapy Intervention for Reducing Risk in Coronary Artery Disease (SPIRR-CAD): Results of an Observer-Blinded, Multicenter, Randomized Trial in Depressed Patients With Coronary Artery Disease.
|
Psychosom Med
|
2016
|
0.75
|
|
134
|
Levosimendan in regional myocardial ischemia.
|
Cardiovasc Drugs Ther
|
2002
|
0.75
|
|
135
|
Phosphorylation of the cardiac ryanodine receptor by Ca2+/calmodulin-dependent protein kinase II: the dominating twin of protein kinase A?
|
Circ Res
|
2006
|
0.75
|
|
136
|
[Restrictive cardiomyopathy].
|
Herz
|
2005
|
0.75
|
|
137
|
[Dyspnea and normal systolic function].
|
Herz
|
2004
|
0.75
|
|
138
|
Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trial.
|
J Hypertens
|
2016
|
0.75
|
|
139
|
[Assessment of risk of sudden cardiac death in patients with hypertrophic cardiomyopathy].
|
Dtsch Med Wochenschr
|
2016
|
0.75
|
|
140
|
CMV promoter is inadequate for expression of mutant human RyR2 in transgenic rabbits.
|
J Pharmacol Toxicol Methods
|
2010
|
0.75
|
|
141
|
Relevance of stretch-induced phosphorylation of MAPK and p90rsk in human myocardium.
|
Front Biosci (Elite Ed)
|
2013
|
0.75
|
|
142
|
Inhibition of osteo/chondrogenic transformation of vascular smooth muscle cells by MgCl2 via calcium-sensing receptor.
|
J Hypertens
|
2016
|
0.75
|
|
143
|
Low permanent pacemaker rates following Lotus device implantation for transcatheter aortic valve replacement due to modified implantation protocol.
|
Cardiol J
|
2017
|
0.75
|
|
144
|
[Diagnostics and therapy of diastolic heart failure].
|
MMW Fortschr Med
|
2009
|
0.75
|
|
145
|
Higher plasma levels of MR-pro-atrial natriuretic peptide are linked to less anxiety: results from the observational DIAST-CHF study.
|
Clin Res Cardiol
|
2015
|
0.75
|
|
146
|
[Importance of surfactant proteins B and D for the differential diagnosis of acute dyspnea].
|
Med Klin (Munich)
|
2010
|
0.75
|